Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Heidel

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Advances in Biochemical Engineering/Biotechnology|March 30, 2006
Molecular conjugatesJeremy Heidel, Swaroop Mishra, Mark E Davis
Bioconjugate Chemistry|July 22, 2004
Cyclodextrin-modified polyethylenimine polymers for gene deliverySuzie H Pun, Nathalie C Bellocq, Aijie Liu, et al.
Science Translational Medicine|March 11, 2021
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastomaPriya Kumthekar, Caroline H Ko, Tatjana Paunesku, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Advances in Biochemical Engineering/Biotechnology|March 30, 2006
Molecular conjugatesJeremy Heidel, Swaroop Mishra, Mark E Davis
Bioconjugate Chemistry|July 22, 2004
Cyclodextrin-modified polyethylenimine polymers for gene deliverySuzie H Pun, Nathalie C Bellocq, Aijie Liu, et al.
Science Translational Medicine|March 11, 2021
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastomaPriya Kumthekar, Caroline H Ko, Tatjana Paunesku, et al.
Pageof 1